Dr. Cheng is a global leader with decades of experience in life sciences innovation and business strategy, with a strong scientific foundation in biology and biomedical engineering. Dr. Cheng’s leadership at ATCC is driven by her commitment to enabling scientific discovery at a rapid pace through the application of digital and physical biological content. Prior to her appointment as CEO, Ruth was senior vice president and general manager, Research & Industrial Solutions, leading strategic partnerships, product development, sales and marketing, and external innovation efforts. She also led ATCC’s R&D and BioNexus scientific teams. Her leadership positioned the company into areas important to ATCC’s future including bioinformatics and biological reference data. Additionally, Ruth expanded the number and diversity of its scientific strategic partnerships and has contributed to the continuous transformation of our culture and strategy.